3,148
Views
6
CrossRef citations to date
0
Altmetric
Diabetes

Hypoglycemia in children with type 1 diabetes: unawareness is a concrete risk

, , &
Pages 1487-1491 | Received 05 Apr 2016, Accepted 18 Apr 2016, Published online: 17 May 2016

References

  • Patterson CC, Dahlquist GG, Gyurus E, et al. Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet 2009;373:2027-33
  • International Diabetes Federation. IDF Diabetes Atlas, 7th edn. Brussels: IDF, 2015. Available at: http://www.idf.org/diabetesatlas [Last accessed 15 April 2016]
  • DIAMOND project group. Incidence and trends of childhood type 1 diabetes worldwide 1990–1999. Diabet Med 2006;23:857-66
  • Osservatorio Epidemiologico Regionale – Regione Autonoma della Sardegna. Il registro del diabete di tipo 1 in età pediatrica in Sardegna. Available at: http://www.www.regione.sardegna.it/documenti/1_19_20120702174709.pdf [Last accessed 15 April 2016]
  • IDF. Global IDF/ISPAD guideline for diabetes in childhood and adolescence. Pediatr Diabetes 2014. Available at: http://www.idf.org/guideline-diabetes-childhood. [Last access 30 March 2016]
  • Nathan DM, Bebu I, Braffett BH, et al. Diabetes Control and Complications Trial (DCCT) – Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group, Nathan DM, et al. Risk factors for cardiovascular disease in type 1 diabetes. Diabetes 2016: published online 19 February 2016, doi: 10.2337/db15-1517
  • Clarke W, Jones T, Rewers A, et al. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes 2008;9:165-74
  • Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 2013;36:1384-95
  • McNeilly AD, McCrimmon RJ. The Scylla and Charybdis of glucose control in childhood type 1 diabetes? Pediatr Diabetes 2015;16:235-41
  • Shaefer C, Hinnen D, Sadler C. Hypoglycemia and diabetes: increased need for awareness. Curr Med Res Opin 2016: published online 9 March 2016, doi: 10.1185/03007995.2016.1163255
  • Conget I, Avila D, Gimenez M, et al. Impaired awareness of hypoglycaemia in subjects with type 1 diabetes. Results of an online survey in a diabetes web site. Endocrinol Nutr 2016;63:121-5
  • Sejling AS, Schouwenberg B, Faerch LH, et al. Association between hypoglycaemia and impaired hypoglycaemia awareness and mortality in people with type 1 diabetes mellitus. Diabet Med 2016;33:77-83
  • Bulsara MK, Holman CDJ, Davis EA, Jones TW. Evaluating risk factors associated with severe hypoglycaemia in epidemiology studies: what method should we use? Diabetes 2004;21:914-19
  • Gonder-Frederick LA, Fisher CD, Ritterband LM, et al. Predictors of fear of hypoglycemia in adolescents with type 1 diabetes and their parents. Pediatr Diabetes 2006;7:215-22
  • Patton SR, Dolan LM, Henry R, Powers SW. Fear of hypoglycemia in parents of young children with type 1 diabetes mellitus. J Clin Psychol Med Settings 2008;15:252-9
  • Blasetti A, Di Giulio C, Tocco AM, et al. Variables associated with severe hypoglycaemia in children and adolescents with type 1 diabetes: a population-based study. Pediatr Diabetes 2011;12:4-10
  • Rankin D, Elliot J, Heller S, et al. Experiences of hypoglycemia unawareness amongst people with type 1 diabetes: a qualitative investigation. Chronic Illn 2014;10:180-91
  • Monami M, Marchionni N, Mannucci E. Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis. Diabetes Obes Metab 2009;11:372-8
  • Chase HP, Dixon B, Pearson J, et al. Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin. J Pediatr 2003:143:704-66
  • Craig ME, Handelsman P, Donaghue KC, et al. Predictors of glycaemic control and hypoglycaemia in children and adolescents with type 1 diabetes from NSW and the ACT. Med J Aust 2002;177: 235-8
  • Lteif AN, Schwenk WF. Type 1 diabetes mellitus in early childhood: glycemic control and associated risk of hypoglycemic reaction. Mayo Clin Proc 1999;74:211-16
  • Cameron FJ. The impact of diabetes on brain function in childhood and adolescence. Pediatr Clin North Am 2015;62:911-27
  • Tonoli C, Heyman E, Roelands B, et al. Type 1 diabetes-associated cognitive decline: a meta-analysis and update of the current literature. J Diabetes 2014;6:499-513
  • Puczynski MS, Puczynski SS, Reich J, et al. Mental efficiency and hypoglycaemia. J Dev Behav Pediatr 1990;11:170-4
  • Hershey T, Craft S, Bhargava N, White NH. Memory and insulin dependent diabetes mellitus (IDDM): effects of childhood onset and severe hypoglycaemia. J Int Neuropsychol Soc 1997;3:509-20
  • Sachon C, Grimaldi A, Digy JP, et al. Cognitive function, insulin-dependent diabetes and hypoglycaemia. J Intern Med 1992;231:471-5
  • Draelos MT, Jacobson AM, Weinger K, et al. Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycaemia. Am J Med 1995;98:135-44
  • Bendtson I, Gade J, Theilgaard A, Binder C. Cognitive function in type 1 (insulin-dependent) diabetic patients after nocturnal hypoglycaemia. Diabetologia 1992;35:898-903
  • Blasetti A, Chiuri RM, Tocco AM, et al. The effect of recurrent severe hypoglycaemia on cognitive performance in children with type 1 diabetes: a meta-analysis. J Child Neurol 2011;26:1383-91
  • The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group, Jacobson AM, Musen G, et al. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 2007;356:1842-52
  • Ryan CM. Why is cognitive dysfunction associated with the development of diabetes early in life? The diathesis hypothesis. Pediatr Diabetes 2006;7:289-97
  • Sanofi. Sanofi receives FDA approval of once-daily basal insulin Toujeo. Paris, France, 26 February 2015. Available at: http://hugin.info/152918/R/1897483/673465.pdf. [Last accessed 1 April 2016]
  • Ratner RE, Gough SC, Mathieu C, et al. Hypoglycemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials. Diab Obes Metab 2013;15:175-84
  • Sinha VP, Howey DC, Choi SL, et al. Steady-state pharmacokinetics and glucodynamics of the novel, long-acting basal insulin LY2605541 dosed once-daily in patients with type 2 diabetes mellitus. Diab Obes Metab 2014;16:344-50
  • Ritzel R, Roussel R, Bolli GB, et al. Patient-level meta-analysis on the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes. Diabetes Obes Metab 2015;17:859-67
  • Fredheim S, Johansen A, Thorsen SU, et al. Nationwide reduction in the frequency of severe hypoglycemia by half. Acta Diabetol 2015;52:591-9
  • Grey M, Whittemore R, Jeon S, et al. Internet psycho-education programs improve outcomes in youth with type 1 diabetes. Diabetes Care 2013;36:2475-82
  • Sawtell M, Jamieson L, Wiggins M, et al. Implementing a structured education program for children with diabetes: lessons learnt from an integrated process evaluation. BMJ Open Diabetes Res Care 2015;3:e000065
  • Hermanns N, Kulzer B, Ehrmann D, et al. The effect of a diabetes education programme (PRIMAS) for people with type 1 diabetes: results of a randomized trial. Diabetes Res Clin Pract 2013;102:149-57
  • Ehrmann D, Bergis-Jurgan N, Haak T, et al. Comparison of the efficacy of a Diabetes Education Programme for type 1 diabetes (PRIMAS) in a randomized controlled trial setting and the effectiveness in a routine care setting: results of a comparative effectiveness study. PLoS One 2016;11:e0147581
  • The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-76
  • The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009;32:1378-83
  • The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Sustained benefit of continuous glucose monitoring on A1c, glucose profile, and hypoglycemia in adults with type 1 diabetes. Diabetes Care 2009;32:2047-9
  • Dassau E, Cameron F, Lee H, et al. Real-time hypoglycemia prediction suite using a continuous glucose monitoring. Diabetes Care 2010;33:1249-54
  • Buse JB, Kudva YC, Battelino T, et al. Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study. Diabetes Technol Ther 2012;14:644-7
  • Slover RH, Welsh JB, Criego A, et al. Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study. Pediatr Diabetes 2012;13:6-11
  • Zalzali M, Houdelet-Guerinot V, Socquard E, et al. Continuous glucose monitoring and hypoglycemia unawareness in type 1 diabetes: a pilot study. Minerva Endocrinol 2015: published online 10 July 2015, doi: unavailable
  • Choudhary P, Ramasamy S, Green L, et al. Real-time continuous glucose monitoring significantly reduces severe hypoglycemia in hypoglycemia-unaware patients with type 1 diabetes. Diabetes Care 2013;36:4160-2
  • Frier BM. How hypoglycemia can affect the life of a person with diabetes. Diabetes Metab Res Rev 2008;24:87-92
  • Wagner VM, Grabert M, Holl RW. Severe hypoglycemia, metabolic control and diabetes management in children with type 1 diabetes in the decade after the Diabetes Control and Complications Trial – a large-scale multicentre study. Eur J Pediatr 2005;164:73-9
  • Heller SR. Minimizing hypoglycemia while maintaining glycemic control in diabetes. Diabetes 2008;57:3177-83
  • Dagogo-Jack S, Fanelli CG, Cryer PE. Durable reversal of hypoglycemia unawareness in type 1 diabetes. Diabetes Care 1999;22:866-7
  • Edwards D, Noyes J, Lowes L, et al. An ongoing struggle: a mixed-method systematic review of interventions, barriers and facilitators to achieving optimal self-care by children and young people with type 1 diabetes in educational settings. BMC Pediatr 2014;14:228

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.